Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

SAKK 17/16

Name: Lurbinectedin monotherapy is active in progressive malignant pleural mesothelioma: SAK 17/16 results
Uploaded: 2019-09-29T00:00:00Z
Duration: 2 min 28 s

Sorry, no posts matched your criteria.

SAKK 17/16

Cookie settings